4.8 Review

Innate lymphoid cells in the initiation, regulation and resolution of inflammation

Journal

NATURE MEDICINE
Volume 21, Issue 7, Pages 698-708

Publisher

NATURE PORTFOLIO
DOI: 10.1038/nm.3892

Keywords

-

Funding

  1. US National Institutes of Health (NIH) [DP5OD012116]
  2. National Institute of Allergy and Infectious Disease Mucosal Immunology Studies Team (MIST) Scholar Award in Mucosal Immunity
  3. Institute for Translational Medicine and Therapeutics Transdisciplinary Program in Translational Medicine and Therapeutics from the US National Center for Research Resources [UL1-RR024134]
  4. NIH [AI061570, AI074878, AI095466, AI095608, AI102942, AI097333, AI106697]
  5. Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award
  6. Crohn's and Colitis Foundation of America

Ask authors/readers for more resources

A previously unappreciated cell type of the innate immune system, termed innate lymphoid cells (ILCs), has been characterized in mice and humans and found to influence the induction, regulation and resolution of inflammation. ILCs have an important role in these processes in mouse models of infection, inflammation and tissue repair. Further, disease-association studies in defined patient populations have identified significant alterations in ILC responses, suggesting a potential role for these cell populations in human health and disease. In this review we discuss the emerging family of ILCs, the role of ILCs in inflammation, and how current or novel therapeutic strategies could be used to selectively modulate ILC responses and limit chronic inflammatory diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available